Table 1.

Demographics of the participants.

CharacteristicsTotal, n = 33
Female, n29
Median age, yrs (IQR)51 (39–59)
Time since diagnosis
  ≤ 1 yr12
  > 1 to ≤ 2 yrs12
  > 2 to 5 yrs9
Median time since medication, mos (IQR)13 (6–19)
Diagnosis
  RA23
  PsA10
No. DMARD
  112
  > 121
  • IQR: interquartile range; RA: rheumatoid arthritis; PsA: psoriatic arthritis; DMARD: disease-modifying antirheumatic drug.